Easy access to tools and additional resources for managing your trial
Don't have a password yet?
Click here.
The study, called LIFE-BTK, is assessing the safety and effectiveness of Abbott's new Esprit™ BTK scaffold. Patient enrollment is complete for the LIFE-BTK clinical study. However, patient enrollment is active for the LIFE-BTK PK SUB-STUDY. The Esprit™ BTK is designed to treat blocked arteries below the knee, or critical limb ischemia, in people battling advanced stages of disease of the arteries outside of the heart, called peripheral artery disease (PAD).
Help is available to ensure patients can return for the follow-up:
Check out this article to learn more about the importance of clinical studies.
As seen on Access Health airing on Lifetime Television‡:
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Precautions
Please be sure to read it.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.
Are you a healthcare professional?
Test
